AlphaYouTM
Congress trade
Rep. Thomas MacArthur (R-NJ) bought $1K-$15K of Vertex Pharmaceuticals Incorporated (VRTX) stock
Thomas MacArthur, U.S. Representative (R-NJ), disclosed a purchase of Vertex Pharmaceuticals Incorporated (VRTX) stock worth $1K-$15K in a STOCK Act filing on Dec 2, 2016.
The trade happened on Nov 2, 2016, 30 days before it was made public.
VRTX has moved +547.1% since the trade date, from $78.00 to $504.73 (Oct 2, 2026 close).
- Traded
- Nov 2, 2016
- Disclosed
- Dec 2, 2016
- Filing delay
- 30 days
- Price since
- +547.1%
- Source
- STOCK Act disclosure
Other trades in this disclosure (26)
- SellCVS$100K-$250KDec 2, 2016
- SellPFF$100K-$250KDec 2, 2016
- BuyXLP$100K-$250KDec 2, 2016
- SellLQD$50K-$100KDec 2, 2016
- SellADNT$15K-$50KDec 2, 2016
- BuyCRRFY$15K-$50KDec 2, 2016
- BuyCRRFY$15K-$50KDec 2, 2016
- BuyEADSY$15K-$50KDec 2, 2016
- BuyHSBC$15K-$50KDec 2, 2016
- SellINFO$15K-$50KDec 2, 2016
- BuyIONS$15K-$50KDec 2, 2016
- SellNVS$15K-$50KDec 2, 2016
- SellVNQ$15K-$50KDec 2, 2016
- BuyACN$1K-$15KDec 2, 2016
- SellADNT$1K-$15KDec 2, 2016
- SellADNT$1K-$15KDec 2, 2016
- SellADNT$1K-$15KDec 2, 2016
- SellCVS$1K-$15KDec 2, 2016
- SellCVS$1K-$15KDec 2, 2016
- BuyIONS$1K-$15KDec 2, 2016
More VRTX insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.